Aclaris Therapeutis (ACRS) PT Raised to $38 at Cantor Fitzgerald
Tweet Send to a Friend
Cantor Fitzgerald analyst Louise Chen raised the price target on Aclaris Therapeutis (NASDAQ: ACRS) to $38.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
